202 related articles for article (PubMed ID: 19718710)
1. RNA splicing factors regulated by HPV16 during cervical tumour progression.
Mole S; McFarlane M; Chuen-Im T; Milligan SG; Millan D; Graham SV
J Pathol; 2009 Nov; 219(3):383-91. PubMed ID: 19718710
[TBL] [Abstract][Full Text] [Related]
2. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus regulation of SR proteins.
McFarlane M; Graham SV
Biochem Soc Trans; 2010 Aug; 38(4):1116-21. PubMed ID: 20659014
[TBL] [Abstract][Full Text] [Related]
4. Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3'-splice site on the HPV-16 genome.
Somberg M; Schwartz S
J Virol; 2010 Aug; 84(16):8219-30. PubMed ID: 20519389
[TBL] [Abstract][Full Text] [Related]
5. Human Papillomavirus E2 Regulates SRSF3 (SRp20) To Promote Capsid Protein Expression in Infected Differentiated Keratinocytes.
Klymenko T; Hernandez-Lopez H; MacDonald AI; Bodily JM; Graham SV
J Virol; 2016 May; 90(10):5047-58. PubMed ID: 26962216
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing.
Dhanjal S; Kajitani N; Glahder J; Mossberg AK; Johansson C; Schwartz S
J Biol Chem; 2015 May; 290(21):13354-71. PubMed ID: 25878250
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF.
Mole S; Milligan SG; Graham SV
J Virol; 2009 Jan; 83(1):357-67. PubMed ID: 18945764
[TBL] [Abstract][Full Text] [Related]
8. Regulation of human papillomavirus gene expression by splicing and polyadenylation.
Johansson C; Schwartz S
Nat Rev Microbiol; 2013 Apr; 11(4):239-51. PubMed ID: 23474685
[TBL] [Abstract][Full Text] [Related]
9. Depletion of HPV16 early genes induces autophagy and senescence in a cervical carcinogenesis model, regardless of viral physical state.
Hanning JE; Saini HK; Murray MJ; Caffarel MM; van Dongen S; Ward D; Barker EM; Scarpini CG; Groves IJ; Stanley MA; Enright AJ; Pett MR; Coleman N
J Pathol; 2013 Nov; 231(3):354-66. PubMed ID: 23913724
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of cellular RNA-binding proteins in HPV-induced neoplasia and cervical cancer.
Fay J; Kelehan P; Lambkin H; Schwartz S
J Med Virol; 2009 May; 81(5):897-907. PubMed ID: 19319956
[TBL] [Abstract][Full Text] [Related]
11. SF2/ASF binds the human papillomavirus type 16 late RNA control element and is regulated during differentiation of virus-infected epithelial cells.
McPhillips MG; Veerapraditsin T; Cumming SA; Karali D; Milligan SG; Boner W; Morgan IM; Graham SV
J Virol; 2004 Oct; 78(19):10598-605. PubMed ID: 15367627
[TBL] [Abstract][Full Text] [Related]
12. Regulation of SRp20 exon 4 splicing.
Jumaa H; Nielsen PJ
Biochim Biophys Acta; 2000 Nov; 1494(1-2):137-43. PubMed ID: 11072076
[TBL] [Abstract][Full Text] [Related]
13. E6/E7 and E6
Artaza-Irigaray C; Molina-Pineda A; Aguilar-Lemarroy A; Ortiz-Lazareno P; Limón-Toledo LP; Pereira-Suárez AL; Rojo-Contreras W; Jave-Suárez LF
Front Immunol; 2019; 10():1676. PubMed ID: 31396215
[TBL] [Abstract][Full Text] [Related]
14. Control of the papillomavirus early-to-late switch by differentially expressed SRp20.
Jia R; Liu X; Tao M; Kruhlak M; Guo M; Meyers C; Baker CC; Zheng ZM
J Virol; 2009 Jan; 83(1):167-80. PubMed ID: 18945760
[TBL] [Abstract][Full Text] [Related]
15. Genome-Wide Profiling of Cervical RNA-Binding Proteins Identifies Human Papillomavirus Regulation of RNASEH2A Expression by Viral E7 and E2F1.
Xu J; Liu H; Yang Y; Wang X; Liu P; Li Y; Meyers C; Banerjee NS; Wang HK; Cam M; Lu W; Chow LT; Xie X; Zhu J; Zheng ZM
mBio; 2019 Jan; 10(1):. PubMed ID: 30696738
[TBL] [Abstract][Full Text] [Related]
16. The Transcriptional Cofactor VGLL1 Drives Transcription of Human Papillomavirus Early Genes via TEAD1.
Mori S; Takeuchi T; Ishii Y; Kukimoto I
J Virol; 2020 May; 94(10):. PubMed ID: 32132238
[TBL] [Abstract][Full Text] [Related]
17. Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes.
Li X; Johansson C; Cardoso Palacios C; Mossberg A; Dhanjal S; Bergvall M; Schwartz S
PLoS One; 2013; 8(9):e72776. PubMed ID: 24039800
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA.
Ropers D; Ayadi L; Gattoni R; Jacquenet S; Damier L; Branlant C; Stévenin J
J Biol Chem; 2004 Jul; 279(29):29963-73. PubMed ID: 15123677
[TBL] [Abstract][Full Text] [Related]
19. RNA-Seq Analysis of Differentiated Keratinocytes Reveals a Massive Response to Late Events during Human Papillomavirus 16 Infection, Including Loss of Epithelial Barrier Function.
Klymenko T; Gu Q; Herbert I; Stevenson A; Iliev V; Watkins G; Pollock C; Bhatia R; Cuschieri K; Herzyk P; Gatherer D; Graham SV
J Virol; 2017 Dec; 91(24):. PubMed ID: 29021401
[TBL] [Abstract][Full Text] [Related]
20. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.
Petersen-Mahrt SK; Estmer C; Ohrmalm C; Matthews DA; Russell WC; Akusjärvi G
EMBO J; 1999 Feb; 18(4):1014-24. PubMed ID: 10022843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
